ALNY

ALNYLAM PHARMACEUTICALS INC

ALNY·02043Q107·US·Common Stock·Healthcare - Biotechnology-13D/G

ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 295 institutional investors as of Q2 2026. Largest holders: FMR LLC ($4.5B), Capital World Investors ($3.4B), BlackRock, Inc. ($3.3B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 153 funds bought ALNY.

295
Holders
(19 Elite)
$36.9B
Total Value
51% (299)
Consensus
153 buying - 146 selling
13F: Insider & Congress: Updated regularly
ALNY

Smart Money Verdict

View all
Loading verdict
Held by 295 funds
19 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 6, 2026 · Activists May 14, 2026 · Congress Sep 9, 2026

InsiderSBSUPRAN BRYANSell $399KOct 2, 2026
InsiderGYGreenstreet YvonneVest 107 shSep 19, 2026
CongressCBCory A. BookerSale $1,001 - $15,000Aug 11, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
15M(+3.0%)$4.5B0.2%+24.79%
39
Increased
11.1M(+3.2%)$3.4B0.4%+17.44%
39
Increased
10.9M(+4.4%)$3.3B0.0%-17.39%
33
Increased
9.8M(+3.0%)$2.9B0.4%-11.02%
39
Increased
6.5M(+0.7%)$2B0.1%-29.22%
32
Increased
6M(+1.4%)$1.8B0.0%-29.18%
32
Decreased
3.8M(-7.9%)$1.1B0.1%-36.31%
0
Increased
3.6M(+7.0%)$1.1B0.0%+60.04%
34
Decreased
2.6M(-0.9%)$791.3M0.0%+38.68%
0
Decreased
2.7M(-57.7%)$785.3M0.0%-35.55%
0
Decreased
2.4M(-2.2%)$734.5M0.7%+129.48%
0
Increased
2.1M(+9.0%)$635.3M0.1%+50.00%
41
Increased
2M(+48.9%)$598.3M2.1%-16.80%
74
Increased
2M(+1.4%)$588.6M0.3%+135.19%
38
Decreased
1.9M(-5.8%)$564.7M0.4%-30.83%
0
Increased
1.9M(+2.9%)$558.1M0.2%+12.35%
39
Decreased
1.3M(-7.1%)$379.1M0.3%-30.03%
0
Decreased
1.1M(-19.8%)$345.9M0.0%+84.89%
0
Increased
1.1M(+4.3%)$332.4M0.2%-32.08%
39
Increased
1M(+2.9%)$310.7M0.0%-20.16%
32

Showing 1-20 of 304

1 / 16
ALNYALNYALNYLAM PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used